Skip to main content

1 Result(s)

within R. Bohmer Remove this filter Biomedicine Remove this filter Cancer Research Remove this filter

and

  1. Article

    Open Access

    Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

    AGITG DOCTOR was a randomised phase 2 trial of pre-operative cisplatin, 5 fluorouracil (CF) followed by docetaxel (D) with or without radiotherapy (RT) based on poor early response to CF, detected via PET, for...

    R. Mercieca-Bebber, E. H. Barnes, K. Wilson, Z. Samoon, E. Walpole, T. Mai… in BMC Cancer (2022)

    Download PDF (2261 KB) View Article